Company Overview
- Headquarters
- 1850 NW 69th Ave, Fort Lauderdale FL
- Website
- gbibio.com
- Phone
- (954) 321-****
- Employees
- 91
- Founded in
- 1993
- Industry
- BioTech/Drugs
- NAICS Code
- 5417, 541, 541714, 54, 54171
- SIC Code
- 873, 87
Financials & Stats
Revenue
$15B
Total Funding Amount
$350,000M
Who is GBI Bio
GBI Bio, headquartered in Fort Lauderdale, Florida, is a customer-focused Contract Development Manufacturing Organization (CDMO). As a fully integrated CDMO, GBI Bio employs 91 individuals and generates annual revenue of $15 million. GBI Bio specializes in developing and manufacturing biosimilar and innovative monoclonal antibodies, recombinant proteins, vaccines, Antibody Drug Conjugates (ADCs), and other bioconjugates. Their comprehensive range of services includes cell line development, GMP master cell banking, proof-of-concept development, cell culture, purification, bioconjugation process development, scale-up, GLP pilot manufacturing for Tox animal studies, and cGMP manufacturing with fill & finish for human clinical trials. Beyond core manufacturing, GBI Bio offers comprehensive support for assay development and qualification, analytical and microbiological Quality Control (QC), and Quality Assurance and Regulatory Affairs (QA/RA). Visit GBI Bio online at gbibio.com.
Company Leadership
GBI Bio Industry Tags
GBI Bio Tech Stack
Companies Similar to GBI Bio
Analyze industry trends and opportunities by examining competitors and companies comparable to GBI Bio, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 15M | 4 | Paradise, NV | ||
| 15M | 21 | 2006 | ||
| 14M | 40 | Danvers, MA | 2014 | |
| 14M | 5 | Los Angeles, CA | 1999 | |
| 14M | 6 | Saint Louis, MO | 1991 |